share_log

Baird Maintains Outperform on Inspire Medical Systems, Lowers Price Target to $200

Baird Maintains Outperform on Inspire Medical Systems, Lowers Price Target to $200

贝尔德维持Inspire Medical Systems股票为跑赢市场,但将目标价下调至200美元。
Benzinga ·  08/07 11:40  · 评级/大行评级

Baird analyst Mike Polark maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and lowers the price target from $220 to $200.

Baird分析师Mike Polark将Inspire Medical Systems(纽交所:INSP)评级为增持,并将价格目标从220美元降至200美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发